Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2002
CompletedFirst Submitted
Initial submission to the registry
January 17, 2003
CompletedFirst Posted
Study publicly available on registry
January 20, 2003
CompletedJanuary 11, 2017
March 1, 2005
January 17, 2003
January 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pharmacokinetic parameter comparison
Interventions
Eligibility Criteria
You may qualify if:
- Must understand study procedures and provide written informed consent
You may not qualify if:
- Please contact study site for more information.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uniformed Services University of Health Science
Bethesda, Maryland, 20814 4799, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louis Cantilena, M.D.
Uniformed Services University of Health Science
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 17, 2003
First Posted
January 20, 2003
Study Start
August 1, 2002
Last Updated
January 11, 2017
Record last verified: 2005-03